Medtronic launches UltraLite flow-directed micro catheter worldwide.
This article was originally published in The Gray Sheet
Executive Summary
MEDTRONIC ULTRALITE FLOW-DIRECTED MICRO CATHETER WORLDWIDE LAUNCH was initiated by the firm on July 29. Availability of the device has been broadening since its release on a limited basis in the spring following 510(k) clearance the week of May 13. Developed by Medtronic's Micro Interventional Systems unit, which Medtronic acquired in late 1995 ("The Gray Sheet" Nov. 6, 1995, p. 6), the device is approved for peripheral and cerebral use to treat arteriovenous malformations and fistulas that can lead to a stroke.
You may also be interested in...
Lilly Can Rest Easy As Tirzepatide Scores Phase III Sleep Apnea Win
Topline results from two studies in obstructive sleep apnea among obese adults showed efficacy crossing the 50% threshold that physicians have called clinically meaningful.
China’s Public Payer Wants To Define Innovative Drugs As Those With ‘Novel Benefits’
China’s public payer perceives innovative drugs in a different way from that of the country’s top drug regulator, a former senior healthcare security official with knowledge of the matter reveals. The posture has unnerved pharma companies, which have been hit by sharp price discounts.
Change Is Constant For Pneumococcal Vaccines: US CDC Prepares For Merck’s V116
As Merck’s 21-valent vaccine approaches its 17 June user fee goal, the US CDC’s vaccine committee is looking at new adult age-based recommendations and bracing for a full pipeline led by GSK’s 24-valent candidate.